DR
Dr. Reddy’s Laboratories Ltd ADR
🇩🇪XSTU.RDDAGermanyHealthcare
€9.90EURdown -0.30 (-2.94%)OpenEnd of day6:50 PM
Price€9.90-0.30 (-2.94%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US2561352038
- CUSIP
- Not reported
Company
- Employees
- 27,527
- Headquarters
- Hyderabad, United States
- Website
- https://www.drreddys.com
- CEO
- Mr. Deepak Sapra M.B.A.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Key dates
- Next earnings
- Oct 22, 2026
Highlights
- Market cap
- Not reported
- EPS LTM
- ₹39.83
- P/E LTM
- 34.12
- Div yield
- 0.6%
Fundamentals (LTM)
- Revenue
- ₹332.83B-0.43%down year on year
- Net income
- ₹33.17B-41.61%down year on year
- Gross margin
- 50.15%-13.01%down year on year
- Free cash flow
- ₹15.15B+4.89%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.